Experimental diabetes treated with trigonelline: Effect on β cell and pancreatic oxidative parameters

Fundamental and Clinical Pharmacology

Volumn 27, Issue 3, 2013, Pages 279-287

  Zhou, Jiyin ^a   Zhou, Shiwen ^a   Zeng, Shengya ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidant; Diabetes; Insulin; Oxidative stress; Pancreas; Trigonelline

Indexed keywords

CHOLESTEROL; GLIBENCLAMIDE; GLUCOSE; GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; MALONALDEHYDE; NITRIC OXIDE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TRIGONELLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HOMOGENATE; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; NONHUMAN; OXIDATIVE STRESS; PANCREAS HOMOGENATE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL;

ALKALOIDS; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; INSULIN; INSULIN-SECRETING CELLS; LIPID PEROXIDATION; MALE; MIRABILIS; OXIDATIVE STRESS; PANCREAS; RATS; RATS, WISTAR; STREPTOZOCIN; TRIGLYCERIDES;

EID: 84877801646     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2011.01022.x     Document Type: Article

References (46)

1. Cryer P.E.The barrier of hypoglycemia in diabetes. Diabetes (2008) 57 3169-3176.
2. Babujanarthanam R., Kavitha P., Pandian M.R.Quercitrin, a bioflavonoid improves glucose homeostasis in streptozotocin-induced diabetic tissues by altering glycolytic and gluconeogenic enzymes. Fundam. Clin. Pharmacol. (2010) 24 357-364.
3. Bopp A., De Bona K.S., Belle L.P., Moresco R.N., Moretto M.B.Syzygium cumini inhibits adenosine deaminase activity and reduces glucose levels in hyperglycemic patients. Fundam. Clin. Pharmacol. (2009) 23 501-507.
4. Dieye A.M., Sarr A., Diop S.N. et al.Medicinal plants and the treatment of diabetes in Senegal: survey with patients. Fundam. Clin. Pharmacol. (2008) 22 211-216.
5. Narendhirakannan R.T., Subramanian S.Biochemical evaluation of the protective effect of Aegle marmelos (L.), Corr. leaf extract on tissue antioxidant defense system and histological changes of pancreatic beta-cells in streptozotocin-induced diabetic rats. Drug Chem. Toxicol. (2010) 33 120-130.
6. Fang Y.Z., Yang S., Wu G.Free radicals, antioxidants, and nutrition. Nutrition (2002) 18 872-879.
7. Johansen J.S., Harris A.K., Rychly D.J., Ergul A.Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc. Diabetol. (2005) 4 5.
8. Jain N., Naseem I., Ahmad J.Evaluation of DNA damage and metabolic syndrome parameters in diabetic rabbits supplemented with antioxidants. Fundam. Clin. Pharmacol. (2009) 23 197-205.
9. Giacco F., Brownlee M.Oxidative stress and diabetic complications. Circ. Res. (2010) 107 1058-1070.
10. Neri S., Calvagno S., Mauceri B. et al.Effects of antioxidants on postprandial oxidative stress and endothelial dysfunction in subjects with impaired glucose tolerance and type 2 diabetes. Eur. J. Nutr. (2010) 49 409-416.
11. State Administration of Traditional Chinese Medicine "Chinese Materia Medica" Editorial Board. Chinese Materia Medica (II). Shanghai Science and Technology Press, Shanghai, 1999, pp. 748-749.
12. Jiangsu New Medical College compiled. The second volume of Dictionary of Chinese Medicine. Shanghai People's Publishing House, Shanghai, 1977, pp. 2370-2371.
13. Moorthy R., Prabhu K., Murthy P.Studies on the isolation and effect of orally active hypoglycemic principle from the seeds of fenugreek (Trigonella foenum graecum). Diabetes Bull. (1989) 9 69-72.
14. Mishkinsky J., Joseph B., Sulman F.G.Hypoglycaemic effect of trigonelline. Lancet (1967) 2 1311-1312.
15. van Dijk A.E., Olthof M.R., Meeuse J.C., Seebus E., Heine R.J., van Dam R.M.Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance. Diabetes Care (2009) 32 1023-1025.
16. Olthof M.R., van Dijk A.E., Deacon C.F., Heine R.J., van Dam R.M.Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on incretin hormones. Nutr. Metab. (Lond) (2011) 8 10.
17. Bakuradze T., Lang R., Hofmann T. et al.Antioxidant effectiveness of coffee extracts and selected constituents in cell-free systems and human colon cell lines. Mol. Nutr. Food Res. (2010) 54 1734-1743.
18. Yoshinari O., Igarashi K.Anti-diabetic effect of trigonelline and nicotinic acid, on KK-A(y) mice. Curr. Med. Chem. (2010) 17 2196-2202.
19. Yoshinari O., Sato H., Igarashi K.Anti-diabetic effects of pumpkin and its components, trigonelline and nicotinic acid, on Goto-Kakizaki rats. Biosci. Biotechnol. Biochem. (2009) 73 1033-1041.
20. Zhou J.Y., Zhou S.W., Zhang K.B. et al.Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats. Biol. Pharm. Bull. (2008) 31 1169-1176.
21. Zhou J.Y., Zhou S.W.Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver. Fitoterapia (2011) 82 184-189.
22. Wang J.J., Gao G.W., Gao R.Z., Liu C.A., Ding X., Yao Z.X.Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension. World J. Gastroenterol. (2004) 10 689-693.
23. Zhou J., Zhou S., Tang J. et al.Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats. Eur. J. Pharmacol. (2009) 606 262-268.
24. Moorthy R., Prabhu K.M., Murthy P.S.Anti-hyperglycemic compound (GII) from fenugreek (Trigonella foenum-graecum Linn.) seeds, its purification and effect in diabetes mellitus. Indian J. Exp. Biol. (2010) 48 1111-1118.
25. Otani M., Yamamoto M., Harada M., Otsuki M.Effect of long- and short-term treatments with pravastatin on diabetes mellitus and pancreatic fibrosis in the Otsuka-Long-Evans-Tokushima fatty rat. Br. J. Pharmacol. (2010) 159 462-473.
26. Bonner-Weir S.Life and death of the pancreatic beta cells. Trends. Endocrinol. Metab. (2000) 11 375-378.
27. Cauchi S., El Achhab Y., Choquet H. et al.TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J. Mol. Med. (Berl) (2007) 85 777-782.
28. Grarup N., Rose C.S., Andersson E.A. et al.Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10, 705 Danish subjects: validation and extension of genome-wide association studies. Diabetes (2007) 56 3105-3111.
29. Xu X., D'Hoker J., Stange G. et al.Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell (2008) 132 197-207.
30. Dor Y., Brown J., Martinez O.I., Melton D.A.Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature (2004) 429 41-46.
31. Kaneto H., Nakatani Y., Kawamori D. et al.Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance. Int. J. Biochem. Cell Biol. (2006) 38 782-793.
32. Lenzen S., Drinkgern J., Tiedge M.Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic. Biol. Med. (1996) 20 463-466.
33. Tiedge M., Lortz S., Drinkgern J., Lenzen S.Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes (1997) 46 1733-1742.
34. Haidara M.A., Yassin H.Z., Rateb M., Ammar H., Zorkani M.A.Role of oxidative stress in development of cardiovascular complications in diabetes mellitus. Curr. Vasc. Pharmacol. (2006) 4 215-227.
35. Tota S., Awasthi H., Kamat P.K., Nath C., Hanif K.Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice. Behav. Brain Res. (2010) 209 73-79.
36. Hamblin M., Smith H.M., Hill M.F.Dietary supplementation with vitamin E ameliorates cardiac failure in type I diabetic cardiomyopathy by suppressing myocardial generation of 8-iso-prostaglandin F2alpha and oxidized glutathione. J. Card. Fail. (2007) 13 884-892.
37. Zafra-Stone S., Yasmin T., Bagchi M., Chatterjee A., Vinson J.A., Bagchi D.Berry anthocyanins as novel antioxidants in human health and disease prevention. Mol. Nutr. Food Res. (2007) 51 675-683.
38. Feng Y., Huang S.L., Dou W. et al.Emodin, a natural product, selectively inhibits 11beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice. Br. J. Pharmacol. (2010) 161 113-126.
39. Dosoo D.K., Rana S.V., Offe-Amoyaw K., Tete-Donkor D., Maddy S.Q.Total antioxidant status in non-insulin-dependent diabetes mellitus patients in Ghana. West Afr. J. Med. (2001) 20 184-186.
40. Halliwell B.Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward?Cardiovasc. Res. (2000) 47 410-418.
41. Haluzik M., Nedvidkova J.The role of nitric oxide in the development of streptozotocin-induced diabetes mellitus: experimental and clinical implications. Physiol. Res. (2000) 49(Suppl 1) S37-S42.
42. Stadler K., Bonini M.G., Dallas S. et al.Involvement of inducible nitric oxide synthase in hydroxyl radical-mediated lipid peroxidation in streptozotocin-induced diabetes. Free Radic. Biol. Med. (2008) 45 866-874.
43. Halliwell B., Chirico S.Lipid peroxidation: its mechanism, measurement, and significance. Am. J. Clin. Nutr. (1993) 57 715S-724S; discussion 724S-725S.
44. Wu G., Fang Y.Z., Yang S., Lupton J.R., Turner N.D.Glutathione metabolism and its implications for health. J. Nutr. (2004) 134 489-492.
45. Robertson R.P.Antioxidant drugs for treating beta-cell oxidative stress in type 2 diabetes: glucose-centric versus insulin-centric therapy. Discov. Med. (2010) 9 132-137.
46. Robertson R.P.Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J. Biol. Chem. (2004) 279 42351-42354.